Furthermore, an increasing trend of antibody levels was observed in the homologous, heterologous, and breakthrough infection groups (GMTs: 693.3, 1122.0, and 3130.0; Fig. 1 D ).
← all excerpts
Proteomic and Cellular Characterization of Omicron Breakthrough Infections and a Third Homologous or Heterologous Boosting Vaccination in a Longitudinal Cohort.
1
—
—